Novavax Vaccine Funding; Europe Sees Deeper Slump: Virus Update

(Bloomberg) -- Novavax Inc. was awarded $1.6 billion in U.S. funding to support large-scale manufacturing of its coronavirus vaccine candidate. Any vaccine would likely be limited in how long it ca...